| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Feb 28, 2025 | Mar 4, 2025 | AbbVie Inc. | Director | Sell | 15.0 | -171,837 | -30.64% | ✗ | $35.3M |
| Aug 5, 2024 | Aug 7, 2024 | AbbVie Inc. | Chair | Sell | 15.0 | -66,500 | -12.96% | ✗ | $12.4M |
| Jul 17, 2024 | Jul 19, 2024 | AbbVie Inc. | Chair | Sell | 2.5 | -282,845 | -35.54% | ✓ | $49.5M |
| Feb 28, 2024 | Mar 1, 2024 | AbbVie Inc. | CEO | Sell | 15.0 | -248,865 | -32.41% | ✗ | $44.3M |
| Jul 31, 2023 | Aug 2, 2023 | AbbVie Inc. | CEO | Sell | 15.0 | -78,500 | -11.66% | ✗ | $11.7M |
| Feb 28, 2023 | Mar 2, 2023 | AbbVie Inc. | CEO | Sell | 15.0 | -113,810 | -14.41% | ✗ | $17.6M |
| Feb 24, 2022 | Mar 1, 2022 | AbbVie Inc. | CEO | Sell | 15.0 | -105,422 | -16.52% | ✗ | $15.4M |
| Dec 9, 2021 | Dec 10, 2021 | AbbVie Inc. | CEO | Sell | 2.5 | -174,100 | -30.01% | ✓ | $21.5M |
| Feb 26, 2021 | Mar 2, 2021 | AbbVie Inc. | CEO | Sell | 17.5 | -247,822 | -13.33% | ✓ | $26.5M |
| Nov 9, 2020 | Nov 12, 2020 | AbbVie Inc. | CEO | Sell | 12.5 | -231,604 | -18.78% | ✓ | $22.4M |
| Feb 28, 2020 | Mar 3, 2020 | AbbVie Inc. | CEO | Sell | 16.3 | -88,719 | -16.70% | ✗ | $7.6M |
| Feb 28, 2019 | Mar 4, 2019 | AbbVie Inc. | CEO | Sell | 16.3 | -72,925 | -16.01% | ✗ | $5.8M |
| Dec 11, 2018 | Dec 13, 2018 | AbbVie Inc. | CEO | Sell | 27.5 | -16,850 | -5.42% | ✓ | $1.5M |
| Feb 28, 2018 | Mar 2, 2018 | AbbVie Inc. | CEO | Sell | 7.5 | -87,771 | -21.60% | ✓ | $10.4M |
| Nov 21, 2017 | Nov 24, 2017 | AbbVie Inc. | CEO | Sell | 2.5 | -218,193 | -43.86% | ✓ | $20.5M |
| Aug 7, 2017 | Aug 8, 2017 | AbbVie Inc. | CEO | Sell | 2.5 | -193,131 | -40.65% | ✓ | $13.7M |
| Aug 3, 2017 | Aug 4, 2017 | AbbVie Inc. | CEO | Sell | 8.8 | -87,899 | -23.76% | ✓ | $6.2M |
| May 19, 2017 | May 23, 2017 | AbbVie Inc. | CEO | Sell | 10.0 | -71,235 | -20.04% | ✓ | $4.7M |
| Mar 8, 2017 | Mar 10, 2017 | AbbVie Inc. | CEO | Sell | 15.0 | -72,801 | -17.02% | ✓ | $4.6M |
| Feb 28, 2017 | Mar 2, 2017 | AbbVie Inc. | CEO | Sell | 16.3 | -112,867 | -24.08% | ✗ | $7M |